Global Artificial Intelligence (AI) in Medical Diagnostics Market Size study & Forecast, by Type, Application, End-User, and Regional Forecasts 2025-2035

Description

The Global Artificial Intelligence (AI) in Medical Diagnostics Market is valued at approximately USD 1.33 billion in 2024 and is projected to grow at a staggering CAGR of over 33.14% during the forecast period 2025-2035. The adoption of AI in the field of medical diagnostics has redefined the paradigm of clinical workflows, offering unparalleled improvements in accuracy, speed, and predictive capabilities. AI-powered diagnostic tools, ranging from imaging interpretation algorithms to in vitro data analysis systems, are now streamlining the early detection and diagnosis of critical diseases. With increasing investments in healthcare digitization and data-driven medicine, the market is witnessing a transformative shift, with stakeholders leveraging AI to bolster diagnostic decision-making, reduce error margins, and optimize patient outcomes.

Fueling the surge is the rising global burden of chronic and lifestyle-related diseases, which necessitates faster and more accurate diagnostic solutions. As cardiovascular, neurological, and oncological conditions continue to challenge traditional diagnostics, AI is being deployed to analyze complex datasets with unprecedented precision. For instance, AI algorithms in imaging have demonstrated superior performance in identifying tumors, lesions, and anomalies across modalities such as MRI, CT, and ultrasound. Additionally, the convergence of big data, cloud computing, and AI analytics has opened new frontiers in the interpretation of vast volumes of medical information, ultimately driving forward clinical efficiency and cost-effective diagnostics.

The regional landscape of the AI in medical diagnostics market highlights North America as the dominant player, attributed to robust healthcare infrastructure, high adoption of advanced technologies, and a strong presence of key AI solution providers. The United States, in particular, is spearheading innovation through significant R&D investments and supportive regulatory frameworks that promote AI integration in healthcare. Meanwhile, Europe follows closely, benefiting from strong governmental push towards digital health and widespread AI pilot programs across diagnostic laboratories and hospitals. The Asia Pacific region is poised to experience the fastest growth, primarily driven by rapid urbanization, expanding patient base, and escalating demand for improved healthcare access in countries like China, India, and Japan. Strategic partnerships and government-led AI initiatives are also catalyzing the market expansion in emerging economies.

Major market player included in this report are:

IBM Corporation
Siemens Healthineers
GE HealthCare
Aidoc
PathAI
Tempus Labs
Google Health (Alphabet Inc.)
Butterfly Network Inc.
Arterys Inc.
Zebra Medical Vision
Qure.ai
Digital Diagnostics Inc.
NVIDIA Corporation
Microsoft Corporation
Canon Medical Systems Corporation

Global Artificial Intelligence (AI) in Medical Diagnostics Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

In Vitro Diagnostics
Diagnostic Imaging
Other Types

By Application:

Cardiology
Oncology
Neurology
Obstetrics/Gynecology
Other Applications

By End-User:

Hospitals
Diagnostic Imaging Centers
Diagnostic Laboratories
Other End-Users

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Artificial Intelligence (AI) in Medical Diagnostics Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top-Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global AI in Medical Diagnostics Market Forces Analysis

3.1. Market Forces Shaping the Global AI in Medical Diagnostics Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising Burden of Chronic and Lifestyle-Related Diseases
- 3.2.2. Technological Advancements in AI Algorithms and Big Data Analytics
3.3. Restraints
- 3.3.1. Stringent Regulatory and Compliance Challenges
- 3.3.2. Data Privacy and Security Concerns
3.4. Opportunities
- 3.4.1. Integration with Telemedicine and Remote Diagnostic Services
- 3.4.2. Expansion in Emerging Markets and Aging Populations

Chapter 4. Global AI in Medical Diagnostics Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Buyers
- 4.1.2. Bargaining Power of Suppliers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's Five Forces Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendations & Conclusion

Chapter 5. Global AI in Medical Diagnostics Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. In Vitro Diagnostics
- 5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.2.2. Market Size Analysis, by Region, 2025-2035
5.3. Diagnostic Imaging
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market Size Analysis, by Region, 2025-2035
5.4. Other Types
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market Size Analysis, by Region, 2025-2035

Chapter 6. Global AI in Medical Diagnostics Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Cardiology
- 6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.2.2. Market Size Analysis, by Region, 2025-2035
6.3. Oncology
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market Size Analysis, by Region, 2025-2035
6.4. Neurology
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market Size Analysis, by Region, 2025-2035
6.5. Obstetrics/Gynecology
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market Size Analysis, by Region, 2025-2035
6.6. Other Applications
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market Size Analysis, by Region, 2025-2035

Chapter 7. Global AI in Medical Diagnostics Market Size & Forecasts by Region 2025-2035

7.1. Growth Snapshot, Regional Market
7.2. Top Leading & Emerging Countries
7.3. North America AI in Medical Diagnostics Market
- 7.3.1. U.S. AI in Medical Diagnostics Market
  - 7.3.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.3.2. Canada AI in Medical Diagnostics Market
  - 7.3.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.2.2. Application Breakdown Size & Forecasts, 2025-2035
7.4. Europe AI in Medical Diagnostics Market
- 7.4.1. UK AI in Medical Diagnostics Market
  - 7.4.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.2. Germany AI in Medical Diagnostics Market
  - 7.4.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.3. France AI in Medical Diagnostics Market
  - 7.4.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.4. Spain AI in Medical Diagnostics Market
  - 7.4.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.5. Italy AI in Medical Diagnostics Market
  - 7.4.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.6. Rest of Europe AI in Medical Diagnostics Market
  - 7.4.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.6.2. Application Breakdown Size & Forecasts, 2025-2035
7.5. Asia Pacific AI in Medical Diagnostics Market
- 7.5.1. China AI in Medical Diagnostics Market
  - 7.5.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.2. India AI in Medical Diagnostics Market
  - 7.5.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.3. Japan AI in Medical Diagnostics Market
  - 7.5.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.4. Australia AI in Medical Diagnostics Market
  - 7.5.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.5. South Korea AI in Medical Diagnostics Market
  - 7.5.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.6. Rest of Asia Pacific AI in Medical Diagnostics Market
  - 7.5.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.6.2. Application Breakdown Size & Forecasts, 2025-2035
7.6. Latin America AI in Medical Diagnostics Market
- 7.6.1. Brazil AI in Medical Diagnostics Market
  - 7.6.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.6.2. Mexico AI in Medical Diagnostics Market
  - 7.6.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.2.2. Application Breakdown Size & Forecasts, 2025-2035
7.7. Middle East & Africa AI in Medical Diagnostics Market
- 7.7.1. UAE AI in Medical Diagnostics Market
  - 7.7.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.2. Saudi Arabia AI in Medical Diagnostics Market
  - 7.7.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.3. South Africa AI in Medical Diagnostics Market
  - 7.7.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.4. Rest of Middle East & Africa AI in Medical Diagnostics Market
  - 7.7.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.4.2. Application Breakdown Size & Forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. IBM Corporation
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Portfolio
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Siemens Healthineers
8.4. GE HealthCare
8.5. Aidoc
8.6. PathAI
8.7. Tempus Labs
8.8. Google Health (Alphabet Inc.)
8.9. Butterfly Network Inc.
8.10. Arterys Inc.
8.11. Zebra Medical Vision
8.12. Qure.ai
8.13. Digital Diagnostics Inc.
8.14. NVIDIA Corporation
8.15. Microsoft Corporation
8.16. Canon Medical Systems Corporation